Skip to content
★ Sign in to follow
AW
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€45k
▼ Sales (0 ops.)
—

Latest filing published 11 Dec 2015 for ImmunityBio, Inc., €2,316.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-48.4%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 11 Dec 2015 · 3986 days ago · €2,316
    -61.1%
    Entry US$16.22 · Close at T+365 US$6.31

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Angela Wilson: trading record in brief

Angela Wilson appears in our data through filings on ImmunityBio, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 10 December 2015, with 3 filings.

No open-market sale appears; the market trades are 3 purchases worth €45k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €2,316. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -48.4%. These figures describe past trades and do not predict future prices.

The newest entry dates from 11 December 2015: an open-market purchase of €2,316, in ImmunityBio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Angela Wilson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Chief Financial OfficerExecutivesImmunityBio, Inc.
    2,552 USD0SEC
    167 shares@ US$15.28Common StockSEC:0001209191-15-084836:0
    Canonical exit: 9 Mar 2016 (T+90)
  • ▲
    Chief Financial OfficerExecutivesImmunityBio, Inc.
    1,164 USD0SEC
    76 shares@ US$15.31Common StockSEC:0001209191-15-084836:1
    Canonical exit: 9 Mar 2016 (T+90)
  • ▲
    Chief Financial OfficerExecutivesImmunityBio, Inc.
    46,327 USD0SEC
    3,022 shares@ US$15.33Common StockSEC:0001209191-15-084836:2
    Canonical exit: 9 Mar 2016 (T+90)

3 of 3 declarations